共 41 条
Immunological patterns identifying disease course and evolution in multiple sclerosis patients
被引:35
作者:
Furlan, R
Rovaris, M
Boneschi, FM
Khademi, M
Bergami, A
Gironi, M
Deleidi, M
Agosta, F
Franciotta, D
Scarpini, E
Uccelli, A
Zaffaroni, M
Kurne, A
Comi, G
Olsson, T
Filippi, M
Martino, G
机构:
[1] Ist Sci San Raffaele, Neuroimmunol Unit, I-20132 Milan, Italy
[2] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy
[3] Ist Sci San Raffaele, Neuroimaging Res Unit, I-20132 Milan, Italy
[4] Karolinska Hosp, Neuroimmunol Unit, S-17176 Stockholm, Sweden
[5] IRCCS Fdn Ist Neurol C Mondino, Lab Neuroimmunol, I-27100 Pavia, Italy
[6] Univ Milan, IRCCS, Osped Maggiore Policlin, Dept Neurol Sci, I-20122 Milan, Italy
[7] Univ Genoa, Dept Neurosci Ophthalmol & Genet, Neuroimmunol Unit, I-16132 Genoa, Italy
[8] S Antonio Abate Hosp, Multiple Sclerosis Ctr, I-21013 Gallarate, VA, Italy
关键词:
multiple sclerosis;
chemokines;
cytokines;
real-time RT-PCR;
multivariate analysis;
D O I:
10.1016/j.jneuroim.2005.04.012
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Reliable, and easy to measure, immunological markers able to denote disease characteristics in multiple sclerosis (MS) patients are still lacking. We applied a multivariate statistical analysis on results obtained by measuring-by real-time RT-PCR-mRNA levels of 25 immunological relevant molecules in PBMCs from 198 MS patients. The combined measurement of mRNA levels of IL-1 beta, TNF-alpha, TGF-beta, CCL20 and CCR3 was able to distinguish MS patients from healthy individuals. CXCR5, CCL5, and CCR3 combined mRNA levels identify primary progressive MS patients while TNF-alpha, IL-10, CXCL10 and CCR3 differentiate relapsing MS patients. Our results indicate that multi-parametric analysis of mRNA levels of immunological relevant molecules in PBMCs may represent a successful strategy for the identification of putative peripheral markers of disease state and disease activity in MS patients. (C) 2005 Elsevier B.V All rights reserved.
引用
收藏
页码:192 / 200
页数:9
相关论文